Search Results

There are 18490 results for: content related to: Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients

  1. You have free access to this content
    Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea

    Hepatology

    Volume 32, Issue 4, October 2000, Pages: 803–806, Byung-Cheol Song, Dong Jin Suh, Han Chu Lee, Young-Hwa Chung and Yung Sang Lee

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2000.16665

  2. You have free access to this content
    Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 415–421, Hyun Woong Lee, Heon Ju Lee, Jae Seok Hwang, Joo Hyun Sohn, Jae Young Jang, Ki Jun Han, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong Han Paik, Chun Kyon Lee, Kwan Sik Lee, Chae Yoon Chon and Kwang-Hyub Han

    Version of Record online : 9 NOV 2009, DOI: 10.1002/hep.23323

  3. You have free access to this content
    To stop or not to stop: The quest for long-term viral suppression

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue 3, March 2011, Pages: 420–422, James Fung, Ching-Lung Lai and Man-Fung Yuen

    Version of Record online : 17 FEB 2011, DOI: 10.1111/j.1440-1746.2011.06604.x

  4. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  5. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  6. Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study

    Journal of Medical Virology

    Volume 89, Issue 5, May 2017, Pages: 849–856, Seong Hee Kang, Keunhee Kang, Yeon Jong Eun, Young Sun Lee, Tae Suk Kim, Yang Jae Yoo, Sang Jun Suh, Eileen L. Yoon, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim and Kwan Soo Byun

    Version of Record online : 23 DEC 2016, DOI: 10.1002/jmv.24715

  7. Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 393–397, J. W. Shin, N. H. Park, J. H. Park, J. H. Park, I. D. Jeong, S-J. Bang, K. R. Joo and D. H. Kim

    Version of Record online : 14 MAR 2005, DOI: 10.1111/j.1365-2893.2005.00606.x

  8. Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: 138–146, Y.-C. Chen, S.-F. Huang, C.-M. Chu and Y.-F. Liaw

    Version of Record online : 14 MAR 2011, DOI: 10.1111/j.1365-2893.2011.01450.x

  9. Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues

    Journal of Viral Hepatitis

    Volume 20, Issue 5, May 2013, Pages: 322–327, R. Zoutendijk, M. J. Sonneveld, J. G. P. Reijnders, A. J. van Vuuren, P. Biesta, B. E. Hansen, A. Boonstra and H. L. A. Janssen

    Version of Record online : 5 DEC 2012, DOI: 10.1111/jvh.12033

  10. Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 5, May 2015, Pages: 918–924, Chih-Chien Yao, Chuan-Mo Lee, Chao-Hung Hung, Jing-Houng Wang, Tsung-Hui Hu, Sheng-Nan Lu, Chi-Sin Changchien, Mei-Chin Hsu and Chien-Hung Chen

    Version of Record online : 10 APR 2015, DOI: 10.1111/jgh.12874

  11. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Version of Record online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  12. Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 5, May 2014, Pages: 1049–1055, Hyun Woong Lee, Wonseok Kang, Sang Hoon Ahn, Heon Ju Lee, Jae Seok Hwang, Joo Hyun Sohn, Jae Young Jang, Ki Jun Han, Ja Kyung Kim, Do Young Kim, Yong Han Paik, Chun Kyon Lee, Ik-Seong Choi, Kwan Sik Lee and Kwang-Hyub Han

    Version of Record online : 21 APR 2014, DOI: 10.1111/jgh.12522

  13. You have free access to this content
    Different hepatitis b virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

    Hepatology

    Volume 29, Issue 3, March 1999, Pages: 976–984, Henry L. Y. Chan, Munira Hussain and Anna S. F. Lok

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510290352

  14. Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy

    Journal of Gastroenterology and Hepatology

    Volume 20, Issue 12, December 2005, Pages: 1838–1842, KWAN SOO BYUN, OH SANG KWON, JU HYUN KIM, HYUNG JOON YIM, YUN JUNG CHANG, JIN YONG KIM, JONG EUN YEON, JONG JAE PARK, JAE SEON KIM, YOUNG TAE BAK and CHANG HONG LEE

    Version of Record online : 5 JUL 2005, DOI: 10.1111/j.1440-1746.2005.03952.x

  15. You have free access to this content
    Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 435–444, Yi-Cheng Chen, Chia-Ming Chu and Yun-Fan Liaw

    Version of Record online : 29 SEP 2009, DOI: 10.1002/hep.23348

  16. You have full text access to this OnlineOpen article
    Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients

    Clinical Microbiology and Infection

    Volume 20, Issue 10, October 2014, Pages: O687–O693, D. He, S. Guo, P. Zhu, S. Tao, M. Li, H. Huang, J. Wang, Y. Wang and M. Ding

    Version of Record online : 24 MAR 2014, DOI: 10.1111/1469-0691.12605

  17. You have free access to this content
    Determinants for sustained HBeAg response to lamivudine therapy

    Hepatology

    Volume 38, Issue 5, November 2003, Pages: 1267–1273, Rong-Nan Chien, Chau-Ting Yeh, Sun-Lung Tsai, Chia-Ming Chu and Yun-Fan Liaw

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2003.50458

  18. You have free access to this content
    Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 934–943, Hung-Chih Yang, Chi-Ling Chen, Yueh-Chi Shen, Cheng-Yuan Peng, Chun-Jen Liu, Tai-Chung Tseng, Tung-Hung Su, Wan-Long Chuang, Ming-Lung Yu, Chia-Yen Dai, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen and Jia-Horng Kao

    Version of Record online : 7 FEB 2013, DOI: 10.1002/hep.26121

  19. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  20. You have free access to this content
    Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus-infected patients from childhood to adulthood

    Hepatology

    Volume 63, Issue 1, January 2016, Pages: 74–82, Jia-Feng Wu, Yu-Chun Chiu, Kai-Chi Chang, Huey-Ling Chen, Yen-Hsuan Ni, Hong-Yuan Hsu and Mei-Hwei Chang

    Version of Record online : 29 OCT 2015, DOI: 10.1002/hep.28222